Could this enzyme help remove 'zombie' cells from our tissues?

medicalxpress - Our population is aging. The United Nations reports that by 2050, the number of people age 85 and older on our planet is set to triple. But a longer life span isn't the same as a longer health span (the number of years we spend healthy). Salk Institute sc…

AI Summary: Researchers identified an enzyme that selectively targets senescent “zombie” cells, restoring tissue function in preclinical models and hinting at anti‑aging and therapeutic possibilities. The findings generated excitement for potential disease‑modifying strategies, but experts caution that translating enzyme‑based fixes from mice to humans will require careful safety studies and sober expectations.

#pharmaceuticals #biotech #drugdevelopment #researchfunding #clinicaltrials

22 hrs / medicalxpress


Back to Top / Sat, July 25, 2026, 2:22 am / permalink 27650 / 2 stories in 5 hrs /




Related Stories


Mid‑stage Parkinson trial failure halts drug development plans / 2 months

Gene therapy pioneers win Breakthrough Prize for CRISPR sickle‑cell work / 3 months

New mechanism may explain why many cancer drugs fail / 3 months

First-in-human trial primes immune system to accept donor livers / 3 months

Experimental therapy significantly reduces Parkinson’s toxic protein in early trial / 3 months

Keratin 16 restrains skin inflammation and may guide treatments / 3 months

Avalyn upsizes IPO to raise cash for lung drug trials / 2 months

StackHealth RSS


You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Adolescent Health, Novo Nordisk, Zoonotic Disease, Mergers and Acquisitions and look for the RSS link.





NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.